Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes MellitusNCT06152042BMEAPhase 2Completed2025-05-20Actual
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionNCT06152861Glaukos CorporationPhase 2Unknown2024-08Estimated
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionNCT06153693MLYSPhase 3Completed2024-12-10Actual
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyNCT06154252Cabaletta BioPhase 2, Phase 3Recruiting2028-07Estimated
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical CancerNCT06157151PGENPhase 2Recruiting2026-11-11Estimated
ACP-204 in Adults With Alzheimer's Disease PsychosisNCT06159673ACADPhase 2, Phase 3Recruiting2028-01Estimated
Influenza Viral Challenge Study of CC-42344 in Healthy ParticipantsNCT06160531COCPPhase 2Completed2024-05-03Actual
Study of Olutasidenib and Temozolomide in HGGNCT06161974Rigel PharmaceuticalsPhase 2Recruiting2029-06Estimated
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPNCT06162286Zai Lab (Hong Kong), Ltd.Phase 3Unknown2025-01-01Estimated
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal PolypsNCT06164704UPBPhase 2Completed2025-07-07Actual
A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge ModelNCT06170242ENTAPhase 2Completed2024-06-17Actual
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)NCT06172257OculisPhase 3Completed2026-04-02Actual
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06173531ACADPhase 3Active not recruiting2025-10Estimated
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute SchizophreniaNCT06179108LBRXPhase 2Completed2024-12-04Actual
A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.NCT06185543NRSNPhase 2Terminated2025-09-30Actual
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)NCT06190093OTLKPhase 3Completed2024-11-07Actual
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia GravisNCT06193889Kyverna TherapeuticsPhase 2, Phase 3Recruiting2027-09Estimated
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension StudyNCT06194799ACADPhase 3Enrolling by invitation2029-04Estimated
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)NCT06196879UPBPhase 2Completed2025-12-16Actual
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)NCT06203002Lexicon PharmaceuticalsPhase 2Completed2025-01-14Actual
Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ AdenocarcinomaNCT06206278LianBio LLCPhase 2Terminated2024-05-31Actual
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for BabesiosisNCT0620737060 Degrees Pharmaceuticals LLCPhase 2Recruiting2027-03-01Estimated
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNNCT06209736Omeros CorporationPhase 2Recruiting2026-01Estimated
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCNCT06216301NovoCure GmbHPhase 3Recruiting2028-10Estimated
A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on DialysisNCT06218290UNCYPhase 2Completed2024-05-29Actual
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular DegenerationNCT06223958OCULPhase 3Active not recruiting2026-04-29Estimated
Evaluating LP-10 in Subjects With OLPNCT06233591Lipella Pharmaceuticals, Inc.Phase 2Unknown2025-06-01Estimated
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsNCT06239480PVLAPhase 3Active not recruiting2026-01-14Actual
A Study of ANAVEX3-71 in Adults With SchizophreniaNCT06245213AVXLPhase 2Active not recruiting2025-06-30Estimated
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLCNCT06246110Eikon TherapeuticsPhase 2Active not recruiting2026-12Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.